Marvell (MRVL) Guides Q4 Sales Inline on Call
Tweet
Share
E-mailGet Alerts MRVL Hot Sheet
Price: $237.04 -5.57%
Revenue Growth %: +34.8%
Financial Fact:
Research and development: 222.46M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Revenue Growth %: +34.8%
Financial Fact:
Research and development: 222.46M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
On its Q3 conference call, Marvell (Nasdaq: MRVL) said it expects to report Q4 sales of $775-$825 million, vs. the consensus of $808.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Marvell (MRVL) at Outperform
- JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
- Marvell (MRVL) PT Raised to $310 at UBS
Create E-mail Alert Related Categories
Conference Calls, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
